Loading clinical trials...
Loading clinical trials...
This pilot study aims to evaluate the feasibility of a novel home-based multicomponent exercise program in adults clinically diagnosed with Primary Progressive Aphasia
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Montreal Heart Institute
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT04838301 · Alzheimer Dementia, Late Onset Alzheimer Disease, and more
NCT06739967 · Primary Progressive Aphasia(PPA)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute
Montreal, Quebec
McGill University Research Centre for Studies in Aging (MCSA)
Montreal, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions